Hypothesis
Age‑associated increases in circulating phenylacetic acid (PAA) produced by gut microbes directly promote endothelial senescence, which in turn upregulates tissue factor (TF) and drives thrombin generation, independent of classic inflammatory pathways. Consequently, lowering gut‑derived PAA should reduce coagulant activity and extend healthspan.
Mechanistic Rationale
Recent work shows that age-associated shifts in the gut microbiota elevate circulating phenylacetic acid (PAA), which directly causes endothelial cell senescence 1. This endothelial senescence parallels the rise in PAA during aging and correlates with increased von Willebrand factor and Factor VIII, key drivers of thrombotic risk 1. While age‑related dysbiosis also elevates circulating LPS and reduces butyrate 2, these pathways have been primarily linked to neuroinflammation rather than coagulation. PAA enters the portal circulation and reaches systemic endothelium where it (1) inhibits endothelial nitric oxide synthase (eNOS) through S‑nitrosylation, decreasing NO bioavailability and favoring a procoagulant phenotype, and (2) activates the aryl hydrocarbon receptor (AhR) in endothelial cells, leading to transcriptional up‑regulation of TF and plasminogen activator inhibitor‑1 (PAI‑1). Senescent endothelial cells also secrete SASP factors that further amplify TF expression. This dual hit creates a feed‑forward loop: endothelial senescence → ↑TF → ↑thro





























